Huntleigh Advisors’s Apyx Medical APYX Stock Holding History
Bought
Maintained
Sold
Other funds holding APYX
ACM
SBCM
Huntleigh Advisors's APYX Position: Q3 2026 in Review
Huntleigh Advisors sold out of Apyx Medical (APYX) in Q3 2026, closing a stake of 263,231 shares — an estimated $1.18M sold.
Huntleigh Advisors first reported a position in APYX in Q4 2025 and held it in 3 quarters. The position peaked at $1.18M in Q2 2026. 69 funds tracked by Wall St. Rank hold APYX as of Q3 2026.
- Huntleigh Advisors reported no remaining Apyx Medical position as of Q3 2026 after selling out during the quarter.
- Huntleigh Advisors sold 263,231 Apyx Medical shares in Q3 2026, an estimated $1.18M.
- Huntleigh Advisors first reported a position in Apyx Medical in Q4 2025 and held it in 3 quarters.
- Huntleigh Advisors's Apyx Medical position peaked at $1.18M in Q2 2026.
- 69 funds tracked by Wall St. Rank held Apyx Medical as of Q3 2026.
Based on Huntleigh Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.